CHRS · Coherus Oncology, Inc.

Summary

Coherus Oncology, Inc. filed an 8-K on March 9, 2026, under Item 2.02 disclosing results of operations via Exhibit 99.1 press release, which is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. Item 9.01 lists the press release as Exhibit 99.1 and includes the cover page as Exhibit 104.

Key takeaways

• Form 8-K filed on 2026-03-09
• Item 2.02: Results of Operations disclosed
• Exhibit 99.1: Press release dated March 9, 2026
• Exhibit 104: Cover page Inline XBRL
• Exhibit 99.1 not deemed 'filed' under Section 18